Protein S Deficiency

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 4488 Experts worldwide ranked by ideXlab platform

Vas Novelli - One of the best experts on this subject based on the ideXlab platform.

Flora Peyvandi - One of the best experts on this subject based on the ideXlab platform.

  • anticoagulant treatment with rivaroxaban in Severe Protein S Deficiency
    Pediatrics, 2013
    Co-Authors: Ida Martinelli, Paolo Bucciarelli, Andrea Artoni, Emilio F Fossali, Serena M Passamonti, Armando Tripodi, Flora Peyvandi
    Abstract:

    We report a caSe of a 6-year-old girl with Severe Protein S Deficiency due to a homozygouS mutation and recurrent epiSodeS of Skin necroSiS. She developed purpura fulminanS at birth and a catheter-related venouS thromboSiS complicated by maSSive pulmonary emboliSm at the Sixth day of life. Long-term oral anticoagulant therapy with a vitamin K-antagoniSt waS Started with a therapeutic range of the international normalized ratio of prothrombin time between 2.0 and 3.0. Unfortunately, thiS common range waS not Sufficient becauSe recurrent epiSodeS of warfarin-induced Skin necroSiS developed if the international normalized ratio waS <4.0. Vitamin K antagoniStS decreaSe plaSma level of vitamin K–dependent coagulation ProteinS, including the natural anticoagulant Protein C. In our patient, the hypercoagulable State due to warfarin-induced reduction of Protein C, other than Severe Protein S Deficiency, outweighed the anticoagulant efficacy of the inhibition of procoagulant factorS II, VII, IX, and X. The Switch of anticoagulant therapy from warfarin to rivaroxaban, a direct inhibitor of activated factor X that doeS not inhibit other vitamin K–dependent ProteinS, reSulted in the diSappearance of Skin necroSiS at 1 year of follow-up. Rivaroxaban may be conSidered aS a valid anticoagulant alternative in patientS with Severe inherited Protein S Deficiency and warfarin-induced Skin necroSiS.

Gustavo Januario - One of the best experts on this subject based on the ideXlab platform.

Jerry B Lefkowitz - One of the best experts on this subject based on the ideXlab platform.

  • lupuS anticoagulant and Protein S Deficiency in children with poStvaricella purpura fulminanS or thromboSiS
    The Journal of Pediatrics, 1996
    Co-Authors: Marilyn J Mancojohnson, Rachelle Nuss, Christopher L Moertel, Linda J Jacobson, Sandra J Meech, Adriana Weinberg, Jerry B Lefkowitz
    Abstract:

    AbStract OBJECTIVE: The objective of thiS Study waS to determine the cauSe of purpura fulminanS, diSSeminated intravaScular coagulation, or thromboSiS in Seven children with varicella. All children were found to have a lupuS anticoagulant and acquired Protein S Deficiency. ThromboSiS in five children waS aSSociated with preSumed or documented infection with StreptococcuS. STUDY DESIGN: Coagulation teStS included determinationS of the activated partial thromboplaStin time, the prothrombin time, the dilute RuSSell viper venom time, the prothrombin F 1+2 fragment, the C4b-binding Protein (C4b), total and free Protein S antigen, and clotting activitieS of factorS II, V, VII, and X and of Protein C and Protein S. AutoantibodieS to phoSpholipidS, cardiolipin, and Protein S were determined in enzyme-linked immunoSorbent aSSayS. RESULTS: All children had a lupuS anticoagulant and acquired Protein S Deficiency. ThromboSiS in five children waS aSSociated with preSumed or documented infection with StreptococcuS. All children tranSiently expreSSed free Protein S Deficiency, elevated levelS of IgG, IgM, or both binding to Protein S, the lupuS anticoagulant, and increaSed concentration of the F 1+2 fragment. Four children alSo had antiphoSpholipid or anticardiolipin antibodieS. In one child a purified IgG fraction croSS-reacted with both Protein S and a Specific varicella antigen. CONCLUSIONS: A SubSet of children with varicella infection, Some of whom are coinfected with StreptococcuS, are prone to development of a lupuS anticoagulant and an autoantibody to Protein S, which reSultS in acquired free Protein S Deficiency. Such children are at riSk of having life-threatening thrombotic eventS. (J P EDIATR 1996;128:319-23)

A A Dokras - One of the best experts on this subject based on the ideXlab platform.

  • Warfarin Skin necroSiS in a poStpartum woman with Protein S Deficiency.
    Obstetrics & Gynecology, 1997
    Co-Authors: A Cheng, N S Scheinfeld, B Mcdowell, A A Dokras
    Abstract:

    Background Warfarin-induced Skin necroSiS iS a rare and dangerouS complication affecting 0.01–0.1% of patientS on warfarin. DeficiencieS in Protein C or Protein S in aSSociation with other factorS have been implicated in itS etiology. No report haS deScribed thiS diSorder in the immediate poStpartum period in patientS with Protein S Deficiency. CaSe A 1-week poStpartum woman with known Protein S Deficiency preSented with Skin necroSiS after a previouSly uneventful courSe of warfarin. ConcluSion Reduced levelS of free Protein S during the antepartum and immediate poStpartum periodS prediSpoSe Protein S-deficient women to warfarin Skin necroSiS. PreviouSly uncomplicated courSeS of warfarin do not obviate the poSSibility of Skin necroSiS with future warfarin adminiStrationS. Initiation of low-doSe warfarin with heparin can reduce the likelihood of thiS diSorder.

  • Warfarin Skin necroSiS in a poStpartum woman with Protein S Deficiency.
    Obstetrics and gynecology, 1997
    Co-Authors: A Cheng, N S Scheinfeld, B Mcdowell, A A Dokras
    Abstract:

    Warfarin-induced Skin necroSiS iS a rare and dangerouS complication affecting 0.01-0.1% of patientS on warfarin. DeficiencieS in Protein C or Protein S in aSSociation with other factorS have been implicated in itS etiology. No report haS deScribed thiS diSorder in the immediate poStpartum period in patientS with Protein S Deficiency. A 1-week poStpartum woman with known Protein S Deficiency preSented with Skin necroSiS after a previouSly uneventful courSe of warfarin. Reduced levelS of free Protein S during the antepartum and immediate poStpartum periodS prediSpoSe Protein S-deficient women to warfarin Skin necroSiS. PreviouSly uncomplicated courSeS of warfarin do not obviate the poSSibility of Skin necroSiS with future warfarin adminiStrationS. Initiation of low-doSe warfarin with heparin can reduce the likelihood of thiS diSorder.